|Publication number||USRE33420 E|
|Application number||US 07/247,131|
|Publication date||Nov 6, 1990|
|Filing date||Sep 12, 1988|
|Priority date||Sep 17, 1984|
|Publication number||07247131, 247131, US RE33420 E, US RE33420E, US-E-RE33420, USRE33420 E, USRE33420E|
|Inventors||Marvin L. Sussman, Barry M. Yomtov|
|Original Assignee||Cordis Corporation|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (13), Referenced by (69), Classifications (5), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
.Iadd.This application is a Reissue of application No. 06/924,743 filed on 10/30/86 and issued as U.S. Pat. No. 4,735,204. .Iaddend.
1. Field of the Invention
The present invention relates generally to medical electronic apparatus for applying electrical current to living tissue including programmable apparatus for controlling the electrical current applied therein. More particularly, the present invention relates to a system for controlling the current supplied to an implanted electrode within a body for electrically stimulating a nerve.
2. Description of the Prior Art
Implantable apparatus have been developed in recent years which include an electrode implantable within a living body for electrically stimulating a nerve. Such an apparatus is disclosed in U.S. Pat. No. 3,822,708. In this apparatus, an implantable electrode-carrying device is arranged to be positioned on the spinal cord so that an electric current can be passed through an electrode into a portion of the juxtaposed spinal cord area. The passage of the current into the nerve acts to block electrical pain signals.
More recently, there has been described in U.S. Pat. No. 4,323,073 an apparatus for controlling the direct current applied to living tissue and a method for increasing the current to a predetermined level for a period of time and then decreasing the current. In this manner, no nerve reaction or spasm is caused while the appropriate stimuli is provided for the reduction of pain. This method, however, provides only an automatically modulated output at only one or two levels and does not provide for patient or physician control of the level of stimulation.
Implantable cardiac pacers have utilized programmable devices to establish a desired output in response to transmitted programming signals. Such a device is described in U.S. Pat. No. 4,253,466, where a radio frequency transmitter is used to program an implanted pacemaker. Once programmed, a magnetic field actuated reed relay is used to provide temporary reprogramming and is operable to reset the output to the original setting when the magnetic field is removed.
According to the teaching of the present invention, there is provided a system for controlling an implanted neural stimulator by an externally applied magnetic means. With this system a timing cycle is permanently programmed within an implanted microprocessor to interact with a magnetically actuated reed relay for selective alteration of the amplitude of the stimulator output.
A neural stimulator system including electrode to nerve electrical connections and circuitry as discussed in the prior art (U.S. Pat. Nos. 3,896,817 and 3,841,306) are implanted in a patient. A microprocessor is also implanted beneath the skin of the patient to control the neural stimulator and is programmed to provide a desired output range. The programmed microprocessor monitors the status of a magnetically controlled reed switch implanted proximate the skin surface of the patient to select a desired output. Application of a magnet to the surface of the skin closes the reed switch and this closure is sensed by the microprocessor. If the magnet is removed and the reed switch reopens within a short time, such as within a 0.003 second to 1 second time period, the neural stimulator is turned to the "on" state. The application of the magnet over the reed switch for a second period of time, such as from 2 to 6 seconds, will be sensed by the microprocessor as an instruction to turn the neural stimulator to the "off" state. Application of the magnet for a third period of time, such as some period greater than 6 seconds, causes the output generated by the neural stimulator to increase incrementally from zero up to a preprogrammed maximum output. At a point where the patient and physician determine that the magnitude of the stimulation is sufficient, the magnet is removed and the generated output remains at the level attained at the time of the magnet removal. Such controllability has been found to be highly desirable since neural stimulation can be lost and pain may return when a patient changes positions. In such an instance, the patient can apply the magnet over the implanted neural stimulator to increase the output to a higher selected level to remove the pain.
FIG. 1 is a partially perspective mechanical and partially schematic view of a magnet adjacent an implanted megnetically controlled microprocessor which is actuated by an implanted reed switch for controlling a neural stimulator;
FIG. 2 is a timing diagram of the microprocessor control intervals;
FIG. 3 is a graph of the microprocessor controlled output current versus time;
FIG. 4 is an enlarged fragmentary graphical view of the output current pulses shown in FIG. 3; and
FIG. 5 is a flow chart of the program or protocol of the microprocessor.
Referring now to FIG. 1, there is illustrated therein an implanted neural stimulating apparatus 10 including a microprocessor 11. The microprocessor 11 is implanted within living tissue 12 beneath the skin 14 and controls a neural stimulator including electrodes for carrying electrical current to the nerves in accordance with commonly known principles of neural stimulation. A neural stimulator and an electrode for implantation in a spine adjacent a spinal cord are old in the art. See Hagfors U.S. Pat. No. 3,645,267 issued Feb. 29, 1972 and Hess U.S. Pat. No. 4,285,347 issued Aug. 25, 1981, the disclosures of which are incorporated herein by reference. Electrically coupled to the microprocessor 11 and implanted within the tissue 12 proximate the skin 14 is a magnetically actuated reed switch 16. The reed switch 16 is controlled and switched from its open state to its closed state through application of an external magnet 20. A magnetic field 22 of the magnet 20 penetrates the skin 14 and the tissue 12 to close the reed switch 16.
The closing of the reed switch 16 is sensed by the microprocessor 11 and the sensing initiates a timing cycle, as shown in FIG. 2.
If the magnet 20 is removed within a first period of time, such as 0.003 second to 1 second, the reed switch 16 will reopen and the open condition will be sensed by the microprocessor 11 as an instruction to turn the neural stimulator to its "on" state.
If the magnet 20 is held in place for a period of time exceeding 2 seconds but less than 6 seconds and then removed, the reopening of the reed switch 16 within that period of time is sensed by the microprocessor 11 as an instruction to turn the neural stimulator to an "off" state.
In the event the magnet 20 is held in place against the skin for a period of time greater than 6 seconds, this is sensed by the microprocessor 11 as a signal to begin generation of an output signal periodically increasing in magnitude according to a ramp function and referred to as a magnetic ramp 24.
FIG. 3 is a graph of increasing amplitude of output current (ramp 24) over a period of time. The output current is plotted on the vertical axis increasing from 0 to 8.9 milliamps and the time is plotted on the horizontal axis increasing from 6 seconds to 36 seconds.
Accordingly, if the magnet 20 is held in place for a period greater than 6 seconds but less than 36 seconds, an output current is selected by the microprocessor according to the graph shown in FIG. 3. Microprocessor control of a neural stimulator is old in the art. See the Rise U.S. Pat. No. 4,390,023 issued June 28, 1983, the disclosure of which is incorporated herein by reference.
In the preferred embodiment of the present invention, during the generation of the output current ramp 24, the microprocessor 11 is programmed to periodically increase the output current in increments, such as 0.12 milliamps, each 0.042 second, until the maximum output permanently programmed in the microprocessor is reached. Additionally, the output is generated in a series of three pulses 30, 33, etc. (FIG. 4) such that each burst of three pulses would be incrementally greater than the previous burst.
Heretofore, in the use of certain implantable neural stimulators, the rate of stimulation and the level of output current of amplitude can be changed non-invasively by a physician at implantation or during subsequent office visits. To effect these changes, a totally dedicated device such as a programmer or microprocessor is used. In addition, the patient and/or the physician can activate or de-activate the output of the implanted neural stimulator by the application of a magnet.
However, changes in the patient's position such as from sitting to standing, can cause cessation of efficacious stimulation. In such instances, an office visit to the physician is necessary for re-programming of the implanted neural stimulator to change the output of the stimulator. With the system of the present invention for controlling an implanted neural stimulator, the capability of changing the output current levels within a programmed output current range by use of an externally applied magnet 20 is provided, and the frequency of office visits can be decreased. The patient can then choose that output current level which is most efficacious for both activity level and physical position.
Also, the patient cannot magnetically change the output level to unsafe levels because the physician has preset the maximum output current/amplitude capable of being output by the neural stimulator apparatus 10 controlled by the microprocessor 11
With the neural stimulating apparatus 10 of the present invention, after implantation of the apparatus 10, the physician can program the apparatus to "on" and to a desired rate an output current.
Previously a patient or a physician could turn an implanted neural stimulator to "off" and at a later time to "on" by applying a magnet over the stimulator. When the stimulator was "on", application of the magnet for 2 to 6 seconds would turn the unit "off". Conversely, when the neural stimulator was in "off" mode, the implanted neural stimulator would be turned "on" by application of the magnet for 0.003 to 1 second. The output current and rate would then be those which were programmed by the physician.
In accordance with the teachings of the present invention, addition of the magnetic ramp function (e.g. ramp 24), whose duration is programmed using a dedicated external device by a physician permits the patient and/or the physician to change the output current amplitude. Application of the magnet 20 for periods greater than 6 seconds causes the output current to increase incrementally from 0 to the maximum programmed output current. At a point where the patient and/or the physician determines that the magnitude of the stimulation is efficacious but before the end of the magnetic ramp duration, the magnet 20 is removed and stimulation occurs at that output current level which was obtained at the time of the removal of the magnet 20. The output current 24 will never exceed the maximum current programmed.
When a patient changes position from sitting to standing and finds that neural stimulation is lost, e.g. return of pain, the patient can apply the magnet 20 over the implanted neural stimulating apparatus 10 to increase the output current to a higher level or to a more effective level.
The program or protocol carried out by the microprocessor 11 in response to magnet control or positioning of the magnet 20 adjacent to the neural stimulating apparatus 10 is shown in FIG. 5. The steps followed in executing the program are as follows:
STEP 1. At this step the microprocessor 11 determines whether the program is "on" or "off". For example, if the current output was at the maximum level established by the physician the program would be "off" and the program would go to "yes" output and end or exit the program. If the program is not "off", the microprocessor 11 then goes to Step 2.
STEP 2. At this step, the microprocessor 11 monitors the status of the reed switch 16 and then goes on to Step 3.
STEP 3. Here the microprocessor 11 determines whether the reed switch 16 is still closed. If it is, the program goes on to Step 4.
STEP 4. Here the microprocessor 11 determines whether more than 6 seconds have elapsed. If "no" the program loops back to Step 2. If "yes" the program goes on to Step 10.
STEP 5. If at Step 3 the reed switch is not still closed, the program or microprocessor 11 determines whether it has been closed for 2 seconds. If "yes" the program goes on to Step 6.
STEP 6. Here the program turns off the neural stimulating apparatus 10 and ends or exits the program.
STEP 7. If the answer to Step 5 was "no" the microprocessor 11 then determines whether the switch 16 had been closed for less than 1 second. If the answer is "no" the microprocessor ends or exits the program.
STEP 8. If the answer is "yes", the neural stimulator is turned on and the microprocessor 11 goes on to Step 9.
STEP 9. Here the current amplitude is returned to the originally programmed value and from there the microprocessor 11 ends or exits the program.
STEP 10. If at Step 5 the switch 16 had been closed for more than 6 seconds, the microprocessor 11 goes on to Step 10 and a determination is made as to whether or not the output current is on. If "yes", the microprocessor 11 exits or ends the program. If "no" it goes on to Step 11.
STEP 11. At this step, a determination is made if the magnetic ramp function, i.e., ramp 24, is set. If "no" the microprocessor 11 ends or exits the program. If "yes" the microprocessor 11 goes on to Step 12.
STEP 12. Here the output current is reset to zero.
STEP 13. Here the microprocessor 11 determines whether or not the reed switch 16 is still closed. If "no" the microprocessor 11 ends or exits the program. If "yes" the microprocessor 11 goes on to Step 14.
STEP 14. At this step, the microprocessor 11 causes the value of the output current to increase in levels or steps with three amplitude bursts for each level of increase (such as the amplitude burst 30 and 33 shown in FIG. 4). This will occur until the magnet 20 is removed or the microprocessor 11 makes a determination in Step 15 that the upper level of current has been reached.
STEP 15. At Step 14 the microprocessor 11 is monitoring the increase in current amplitude and when it determines that the amplitude of the current has not reached the maximum amplitude of the current the microprocessor 11 loops back to the beginning of Step 13. If on the other hand, the microprocessor 11 determines that the maximum current of amplitude has been reached, the microprocessor ends or exits the program to stop further increases in output current level.
From the foregoing description, it will be apparent that the neural stimulating apparatus 10 of the present invention and the method for using same allow either the patient or the physician to alter the level of output current using an external magnet 20. Such use of the external magnet 20 for the predetermined period of time initiates an incrementally increasing output current under control of a program in an implanted microprocessor 11, allowing the patient to determine the effective level of output current for efficacious stimulation and then fix the level of the output current at that selected level. Further, the microprocessor 11 is programmed to limit the upper value of output current that can be supplied to electrodes adjacent nerves to be stimulated so that such output current cannot reach an unsafe level.
Further from the foregoing description, it will be apparent that modifications can be made to the apparatus 10 and method for using same without departing from the teachings of the present invention. Accordingly, the scope of the invention is only to be limited as necessitated by the accompanying claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3645267 *||Oct 29, 1969||Feb 29, 1972||Medtronic Inc||Medical-electronic stimulator, particularly a carotid sinus nerve stimulator with controlled turn-on amplitude rate|
|US3669120 *||Jul 9, 1970||Jun 13, 1972||Rovsing As Christian||Device for starting or stimulating heart contractions|
|US3713449 *||Aug 31, 1970||Jan 30, 1973||Mulier P||Cardiac pacer with externally controllable variable width output pulse|
|US3796221 *||Jul 7, 1971||Mar 12, 1974||Hagfors N||Apparatus for delivering electrical stimulation energy to body-implanted apparatus with signal-receiving means|
|US3830242 *||Dec 11, 1972||Aug 20, 1974||Medtronic Inc||Rate controller and checker for a cardiac pacer pulse generator means|
|US3865119 *||Apr 10, 1973||Feb 11, 1975||Siemens Ag||Heartbeat actuator with controlled pulse amplitude|
|US4124031 *||Jun 9, 1977||Nov 7, 1978||Vitatron Medical B.V.||Programmable pacer|
|US4285347 *||Jul 25, 1979||Aug 25, 1981||Cordis Corporation||Stabilized directional neural electrode lead|
|US4390023 *||Apr 30, 1981||Jun 28, 1983||Medtronic, Inc.||Patterned electrical tissue stimulator|
|US4440173 *||Jul 6, 1981||Apr 3, 1984||Medtronic||Programmable body stimulation system|
|US4538624 *||Dec 8, 1982||Sep 3, 1985||Cordis Corporation||Method for lead introduction and fixation|
|US4649936 *||Oct 11, 1984||Mar 17, 1987||Case Western Reserve University||Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking|
|GB985987A *||Title not available|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US5188104 *||Feb 1, 1991||Feb 23, 1993||Cyberonics, Inc.||Treatment of eating disorders by nerve stimulation|
|US5263480 *||Aug 7, 1992||Nov 23, 1993||Cyberonics, Inc.||Treatment of eating disorders by nerve stimulation|
|US6246912||Jul 19, 1999||Jun 12, 2001||Sherwood Services Ag||Modulated high frequency tissue modification|
|US6516227||Jul 26, 2000||Feb 4, 2003||Advanced Bionics Corporation||Rechargeable spinal cord stimulator system|
|US6895280||Nov 27, 2002||May 17, 2005||Advanced Bionics Corporation||Rechargeable spinal cord stimulator system|
|US7526341 *||Mar 15, 2002||Apr 28, 2009||Medtronic, Inc.||Amplitude ramping of waveforms generated by an implantable medical device|
|US7651493||Mar 3, 2006||Jan 26, 2010||Covidien Ag||System and method for controlling electrosurgical snares|
|US7722601||Apr 30, 2004||May 25, 2010||Covidien Ag||Method and system for programming and controlling an electrosurgical generator system|
|US7749217||May 6, 2003||Jul 6, 2010||Covidien Ag||Method and system for optically detecting blood and controlling a generator during electrosurgery|
|US7766693||Jun 16, 2008||Aug 3, 2010||Covidien Ag||Connector systems for electrosurgical generator|
|US7766905||Feb 4, 2005||Aug 3, 2010||Covidien Ag||Method and system for continuity testing of medical electrodes|
|US7780662||Feb 23, 2005||Aug 24, 2010||Covidien Ag||Vessel sealing system using capacitive RF dielectric heating|
|US7824400||Mar 3, 2006||Nov 2, 2010||Covidien Ag||Circuit for controlling arc energy from an electrosurgical generator|
|US7901400||Jan 27, 2005||Mar 8, 2011||Covidien Ag||Method and system for controlling output of RF medical generator|
|US7947039||Dec 12, 2005||May 24, 2011||Covidien Ag||Laparoscopic apparatus for performing electrosurgical procedures|
|US8012150||Apr 30, 2004||Sep 6, 2011||Covidien Ag||Method and system for programming and controlling an electrosurgical generator system|
|US8104956||Oct 23, 2003||Jan 31, 2012||Covidien Ag||Thermocouple measurement circuit|
|US8355792||Apr 13, 2012||Jan 15, 2013||Nevro Corporation||Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods|
|US8359103||Apr 13, 2012||Jan 22, 2013||Nevro Corporation||Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods|
|US8396559||Feb 16, 2012||Mar 12, 2013||Nevro Corporation||Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods|
|US8428748||Apr 13, 2012||Apr 23, 2013||Nevro Corporation|
|US8509905 *||Apr 13, 2012||Aug 13, 2013||Nevro Corporation|
|US8509906||Jul 9, 2012||Aug 13, 2013||Nevro Corporation||Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions|
|US8554326||Mar 14, 2013||Oct 8, 2013||Nevro Corporation|
|US8649874||Nov 30, 2011||Feb 11, 2014||Nevro Corporation||Extended pain relief via high frequency spinal cord modulation, and associated systems and methods|
|US8694109||Dec 21, 2012||Apr 8, 2014||Nevro Corporation|
|US8712533||Apr 22, 2010||Apr 29, 2014||Nevro Corporation|
|US8718781||Dec 27, 2012||May 6, 2014||Nevro Corporation|
|US8718782||Mar 14, 2013||May 6, 2014||Nevro Corporation|
|US8734438||Oct 21, 2005||May 27, 2014||Covidien Ag||Circuit and method for reducing stored energy in an electrosurgical generator|
|US8768472||Dec 4, 2012||Jul 1, 2014||Nevro Corporation||Multi-frequency neural treatments and associated systems and methods|
|US8774926||Dec 4, 2012||Jul 8, 2014||Nevro Corporation||Multi-frequency neural treatments and associated systems and methods|
|US8792988||Sep 25, 2013||Jul 29, 2014||Nevro Corporation|
|US8808161||Oct 23, 2003||Aug 19, 2014||Covidien Ag||Redundant temperature monitoring in electrosurgical systems for safety mitigation|
|US8849410||Apr 5, 2013||Sep 30, 2014||Nevro Corporation||Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions|
|US8862239||Sep 25, 2013||Oct 14, 2014||Nevro Corporation|
|US8868192||Jan 24, 2014||Oct 21, 2014||Nevro Corporation|
|US8874217||Mar 14, 2013||Oct 28, 2014||Nevro Corporation|
|US8874221||Mar 14, 2013||Oct 28, 2014||Nevro Corporation|
|US8874222||Jan 24, 2014||Oct 28, 2014||Nevro Corporation|
|US8880177||Jan 24, 2014||Nov 4, 2014||Nevro Corporation|
|US8886326||Jan 24, 2014||Nov 11, 2014||Nevro Corporation|
|US8886327||Jan 24, 2014||Nov 11, 2014||Nevro Corporation|
|US8886328||Mar 6, 2014||Nov 11, 2014||Nevro Corporation|
|US8892209||Sep 25, 2013||Nov 18, 2014||Nevro Corporation|
|US8989865||Sep 14, 2012||Mar 24, 2015||Nevro Corporation|
|US9180298||Jan 24, 2014||Nov 10, 2015||Nevro Corp.||Extended pain relief via high frequency spinal cord modulation, and associated systems and methods|
|US9278215||Mar 14, 2013||Mar 8, 2016||Nevro Corporation||Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods|
|US9283387||Mar 14, 2013||Mar 15, 2016||Nevro Corporation||Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods|
|US9283388||Mar 14, 2013||Mar 15, 2016||Nevro Corporation||Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods|
|US9295839||Mar 14, 2013||Mar 29, 2016||Nevro Corporation|
|US9327121||Sep 7, 2012||May 3, 2016||Nevro Corporation|
|US9327125||Apr 24, 2014||May 3, 2016||Nevro Corporation|
|US9327126||Oct 10, 2014||May 3, 2016||Nevro Corporation|
|US9327127||Oct 27, 2014||May 3, 2016||Nevro Corporation|
|US9333357||Sep 30, 2014||May 10, 2016||Nevro Corporation|
|US9333358||Sep 30, 2014||May 10, 2016||Nevro Corporation|
|US9333359||Sep 30, 2014||May 10, 2016||Nevro Corporation|
|US9333360||Oct 10, 2014||May 10, 2016||Nevro Corporation|
|US9387327||Oct 23, 2014||Jul 12, 2016||Nevro Corporation|
|US9403013||Sep 10, 2014||Aug 2, 2016||Nevro Corporation||Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions|
|US9409019||Feb 9, 2015||Aug 9, 2016||Nevro Corporation||Linked area parameter adjustment for spinal cord stimulation and associated systems and methods|
|US9480842||Oct 27, 2014||Nov 1, 2016||Nevro Corporation|
|US9522032||May 21, 2014||Dec 20, 2016||Covidien Ag||Circuit and method for reducing stored energy in an electrosurgical generator|
|US9768373||Jan 23, 2015||Sep 19, 2017||Covidien Ag||Switched resonant ultrasonic power amplifier system|
|US20050004628 *||Mar 15, 2002||Jan 6, 2005||Medtronic, Inc||Amplitude ramping of waveforms generated by an implantable medical device|
|USRE40279||Jun 26, 1997||Apr 29, 2008||Sherwood Services Ag||Method and system for neural tissue modification|
|USRE41045||Jun 12, 2003||Dec 15, 2009||Covidien Ag||Method and apparatus for altering neural tissue function|
|WO1992013592A1 *||Jan 30, 1992||Aug 20, 1992||Cyberonics, Inc.||Treatment of eating disorders by nerve stimulation|
|U.S. Classification||607/46, 607/59|
|Sep 27, 1991||FPAY||Fee payment|
Year of fee payment: 4
|Sep 20, 1995||FPAY||Fee payment|
Year of fee payment: 8
|Aug 30, 1999||FPAY||Fee payment|
Year of fee payment: 12